(CYTX) Cytori Therapeutics is Downgraded by B. Riley & Co. to Neutral

Cytori Therapeutics (CYTX) is Downgraded by B. Riley & Co. to Neutral. Earlier the firm had a rating of “Buy ” on the company shares. The Rating was issued on Jul-25-2017.